Hong Kong Pharmaceuticals & Biotech Top Dividend Payers

Essex Bio-Technology

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$6.1b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.3b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$97.0b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Tong Ren Tang Technologies

Market Cap: HK$5.0b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

SSY Group

Market Cap: HK$6.6b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$7.1b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.7b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.